Assignee
XENAMED CORP
US·3 granted patents·4 pending applications·5 citations·filing 2017–2024
Top patents by PatentIndex Score
7 records- 0185US11975103B2Compositions of midodrine and methods of using the sameXENAMED CORP·Filed 2021·Granted May 7, 2024·1 cites·20 claims
- 0285US11202760B2Compositions of midodrine and methods of using the sameXENAMED CORP·Filed 2017·Granted Dec 21, 2021·3 cites·20 claims
- 0377US12213953B2Extended release midodrine hydrochloride compositions and methods of useXENAMED CORP·Filed 2018·Granted Feb 4, 2025·1 cites·18 claims
- 0475US2025120919A1Compositions of midodrine and methods of using the sameXENAMED CORP·Filed 2024·Application pending·0 cites
- 0572US2025228802A1Extended release midodrine hydrochloride compositions and methods of useXENAMED CORP·Filed 2024·Application pending·0 cites
- 0671US2025108026A1Droxidopa compositions and methodsXENAMED CORP·Filed 2024·Application pending·0 cites
- 0745US2019321318A1Droxidopa compositions and methodsXENAMED CORP·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →